About fifteen years ago, our curiosity for microalgae grew from small bench experiments into a journey that reached pilot-scale field trials. Working with strains from Antarctic and local ecosystems, we optimized cultures, built photobioreactors, and established a robust analytical backbone that informs every decision we make.

This body of work has matured in recent years into a product-focused biorefinery approach. We design scalable processes for natural UV protectants, phycobiliproteins, EPS-based hydrogels, and microalgae-derived biostimulants, and we continue optimization without pause. Our separation and purification streams are defined, while stability, safety, and regulatory testing are embedded as non-negotiable steps in our roadmap.

Today, as a young venture approaching its first year, we are building a bridge that carries science to market. With a zero-waste, circular value chain, we aim for carbon-negative impact; and we pursue trusted product families and open collaborations across agriculture, industry, food, biomaterials, cosmetics, pharmaceuticals, and biophilic architecture.